TPBG expression + MET expression	Lung Cancer	TPBG expression + MET expression	Lung Cancer	DM004 Sensitive: D – Preclinical DM004 Sensitive : D	DM004 Sensitive: D – Preclinical DM004 Sensitive : D
TPBG expression + MET expression	Gastric Cancer	TPBG expression + MET expression	Gastric Cancer	DM004 Sensitive: D – Preclinical DM004 Sensitive : D	DM004 Sensitive: D – Preclinical DM004 Sensitive : D
TPBG expression	B Acute Lymphoblastic Leukemia	TPBG expression	B Acute Lymphoblastic Leukemia	PF-06263507 Sensitive: D – Preclinical PF-06263507 Sensitive : D	PF-06263507 Sensitive: D – Preclinical PF-06263507 Sensitive : D
TPBG expression	Cervical Cancer	TPBG expression	Cervical Cancer	KRLS-004 Sensitive: D – Preclinical KRLS-004 Sensitive : D	KRLS-004 Sensitive: D – Preclinical KRLS-004 Sensitive : D
TPBG overexpression	Breast Cancer	TPBG overexpression	Breast Cancer	KRLS-004 Sensitive: D – Preclinical KRLS-004 Sensitive : D	KRLS-004 Sensitive: D – Preclinical KRLS-004 Sensitive : D
TPBG underexpression + HER-2 overexpression	Gastric Cancer	TPBG underexpression + HER-2 overexpression	Gastric Cancer	KRLS-004 Sensitive: D – Preclinical KRLS-004 Sensitive : D	KRLS-004 Sensitive: D – Preclinical KRLS-004 Sensitive : D
TPBG underexpression	Lung Cancer	TPBG underexpression	Lung Cancer	KRLS-004 Sensitive: D – Preclinical KRLS-004 Sensitive : D	KRLS-004 Sensitive: D – Preclinical KRLS-004 Sensitive : D

5T4-targeted antibody-drug conjugate

Associations(7)